JNJ vs OLPX · P/E 17, rev $49.37B vs P/E 70, rev $423.0M
Johnson & Johnson (JNJ) versus Olaplex Holdings Inc (OLPX) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Olaplex Holdings Inc (OLPX) is a specialty retail company listed on US.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported OLPX revenue for 2025-12-31 was $423.0M. Net income was -$9.3M. Revenue was up 0.1% from 2024-12-31 to 2025-12-31. OLPX currently screens at market cap $932.3M and trailing P/E 70.0.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. OLPX currently screens at market cap $932.3M and trailing P/E 70.0.
Not investment advice. Open the JNJ and OLPX stock pages for the full models.
Not investment advice.